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Abstract
Background: The aims of this study were to evaluate the awareness of and attitudes towards the 2005 European
Society of Cardiology (ESC) guidelines for Heart Failure (HF) of the cardiologists in Pakistan and assess barriers to
adherence to guidelines.
Methods: A cross-sectional survey was conducted in person from March to July 2009 to all cardiologists practicing
in 4 major cities in Pakistan (Karachi, Lahore, Quetta and Peshawar). A validated, semi-structured questionnaire
assessing ESC 2005 Guidelines for HF was used to obtain information from cardiologists. It included questions
about awareness and relevance of HF guidelines (See Additional File 1). Respondents’ management choices were
compared with those of an expert panel based on the guidelines for three fictitious patient cases. Cardiologists
were also asked about major barriers to adherence to guidelines.
Results: A total of 372 cardiologists were approached; 305 consented to participate (overall response rate, 82.0%).
The survey showed a very high awareness of CHF guidelines; 97.4% aware of any guideline. About 13.8%
considered ESC guidelines as relevant or very relevant for guiding treatment decisions while 92.8% chose AHA
guidelines in relevance. 87.2% of respondents perceived that they adhered to the HF guidelines. For the patient
cases, the proportions of respondents who made recommendations that completely matched those of the
guidelines were 7% (Scenario 1), 0% (Scenario 2) and 20% (Scenario 3). Respondents considered patient
compliance (59%) and cost/health economics (50%) as major barriers to guideline implementation.
Conclusion: We found important self reported departures from recommended HF management guidelines among
cardiologists of Pakistan.
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Background
The prevalence of heart failure (HF) continues to
increase despite efforts at primary and secondary pre-
vention[1]. Moreover, management of heart failure is
complicated and requires extensive experience and
knowledge of the current guidelines in effect. This can
be tasking as they are updated frequently in accordance
with new research trials and evolving recommendations.
Despite comprehensive guidelines being available, stu-
dies show failure of optimal management in patients
[2-6]. Also, significant variation exists among hospitals
in the implementation of published guidelines[7]. In real
practice, not only is there inadequate prescription of
recommended drugs, but also an issue with polyphar-
macy[4,8]. It is established that adherence to guidelines
for heart failure management guidelines is a strong pre-
dictor of fewer hospitalizations and improved outcome
in CHF patients[5,9-11].
Unlike the situation in developing countries, the South
Asian subcontinent including Pakistan still faces an
increase in mortality due to heart failure[12,13]. Pakistan
is the 6th most populous country in the world at 181
million. It is a developing country with 60% of the
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population living on less than US $2/day[14]. It faces
the double burden of communicable as well as non-
communicable illnesses including HF[15]. Healthcare
provided at government hospitals is very poor. In most
cases, people have to be able to pay for their medical
expenses to receive optimum health care. Hence, the
health system is itself not strong enough to handle the
increasing costs associated with decompensated heart
failure hospitalizations. Studies in Pakistan have demon-
strated a shortfall in management of cardiovascular dis-
orders [16-18] In order to derive effective measures to
improve chronic heart failure management skills among
the cardiologists in Pakistan, it is imperative to assess
their current knowledge and awareness of existing
guidelines. At present, no national guidelines exist in
Pakistan; cardiologists manage patients in accordance
with the AHA or ESC guidelines.
The aim of this study was to evaluate the awareness of
and attitudes of cardiologists in Pakistan towards the
latest ESC guidelines for CHF and assess barriers to
adherence to guidelines.
Methods
Study Design
This cross sectional study was conducted among practi-
cing cardiologists in the capital cities of the four pro-
vinces of Pakistan: Karachi, Lahore, Quetta and
Peshawar in the provinces of Sindh, Punjab, Balochistan
and North Western Frontier Province, respectively. The
study was conducted from March to July 2009.
The study was conducted in compliance with the
Declaration of Helsinki and the Department of Medicine
Ethics committee approved the research protocol.
Informed consent has been obtained from the participants.
Participants
Cardiologist was defined as a physician whose practice
included >80% patients with cardiac diseases, regardless of
post graduate training. We have used the same definition
in our previous paper by Gowani et al[16]. The reason
behind this is the unregulated medical practice in the
country leading to considerable heterogeneity among phy-
sicians practicing cardiology in Pakistan. Hence, this defi-
nition allowed us to capture all practitioners providing
specialty cardiac care in the field, regardless of credentials.
A list of cardiologists in each city was prepared by
reviewing the membership directory maintained by the
Pakistan Cardiac Society. In addition to that marketing
divisions of major pharmaceutical companies doing
business in Pakistan were also contacted to add and
reinforce our list of practicing cardiologists. Further-
more, in each city, we contacted major hospitals
(defined as housing > 100 beds) and procured the
names of the physicians listed as staff cardiologists.
Using this multi pronged approach, a list of cardiologists
was developed for each of the 4 cities.
All cardiologists on our comprehensive list were con-
tacted and invited to participate in the survey. All parti-
cipants signed an informed-consent form. Full
confidentiality was assured and stating the participants’
name on the questionnaire was optional. Cardiologists
practicing at the investigators’ university hospital (Aga
Khan University, Karachi, Pakistan) were excluded from
the study. Cardiologists were approached personally by
interviewers (volunteers) in their offices. If the respon-
dent was busy, a later time was obtained. All question-
naires were filled by respondents while interviewers
present. 80% of the respondents filled the questionnaire
on the first visit. There was no significant difference in
awareness of guidelines between those who responded
immediately and the ones on subsequent visits.
Study Instrument
The questionnaire was adopted from Leif Erhardt et al
with the authors permission[19]. The questionnaire was
developed in English language. Pretesting was carried out
among the cardiologists of the study institution. These
were not approached during data collection. The pretest
sample comprised of 12 respondents. A few amendments
were made to clarify ambiguities in a few parts of the
questionnaire. Trained medical officers then approached
individual cardiologists at their offices, in person, and
invited them to participate. Because all medical education
in Pakistan is conducted in English, we felt confident that
there would be no comprehension issues with an English
language questionnaire. However, the medical officers
were available to answer any inquiries.
The original questionnaire was developed by an expert
panel of European Cardiologists, including two who
were involved in the development and publication of the
2005 ESC guidelines. The expert panel developed three
fictitious patient case scenarios that were designed to
reflect different aspects of the management of patients
with CHF. In summary, they were: a 69-year-old man
with a history of hypertension and myocardial infarction,
newly diagnosed with heart failure; a 70-year-old woman
diagnosed with heart failure 2 years ago, now with
exacerbation of symptoms; and a 75- year-old woman
with CHF and preserved left ventricular function. A
selection of treatment options, including some that were
not consistent with the 2005 ESC guidelines, was pro-
vided. This was adopted from a survey conducted by
Erhardt et al among European Cardiologists with the
permission of their authors[19].
Definitions
Non invasive cardiologist was defined as a practitioner
who does not perform invasive procedures, such as
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coronary angiography or percutaneous coronary inter-
ventions (PCI). Invasive non-interventional cardiologist
was defined as someone who performs invasive diagnos-
tic coronary procedures, such as left and right heart
catheterization and coronary angiography but no inter-
ventions. Interventional cardiologist was defined as
someone who performs PCI or peripheral vascular inter-
vention, in addition to invasive diagnostic procedures.
Teaching hospital was defined as a university- or med-
ical school- affiliated hospital, a hospital that supports a
residency or fellowship program accredited by Pakistan’s
College of Physicians and Surgeons (the country’s regu-
latory body for postgraduate medical education), or a
hospital that met both criteria.
Cardiologist were said to have a bona fide cardiology
qualification if their academic degree required formal
structured cardiology training (e.g., Fellow of the College
of Physician and Surgeons [Pakistan] in cardiology,
member of Royal College of Physicians, American Board
of Internal Medicine subspecialty certification in cardio-
vascular diseases).
Professional meeting was defined as a major profes-
sional society-initiated meeting in the field of cardiology
held anywhere in the world, including Pakistan.
Data Analysis
The data was entered and analyzed in Statistical Package
for Social Sciences 17.0 (SPSS, Inc., Chicago, IL, USA).
Descriptive statistics were performed for physician
demographics and responses to questions on awareness
of guidelines. The results were recorded as frequencies,
means ± standard deviations (SD) and p-values. Tables
and figures were used for comprehensive viewing of the
results.
Results
A total of 372 cardiologists were approached; 305 con-
sented to participate (overall response rate, 82.0%; 85.6%
for Karachi, 81.3% for Lahore, 71.4% for Quetta, 75.5%
for Peshawar). Three hundred and five cardiologists
from four major cities completed the survey: Karachi (n
= 167), Lahore (n = 78), Peshawar (n = 40), Quetta (n =
20). Table 1 shows their background and practice
details. The mean age of the cardiologists was 42.1 ± 9.7
years and 89.2% were males. The mean time period
spent treating heart failure was 12.3 ± 8.6 years. 68.2%
of the cardiologists had completed their postgraduate
training in Pakistan, followed by 26.6% in the UK or
Europe. The majority of cardiologists (82.6%) saw both
inpatients and outpatients in their practice. The average
number of inpatients and outpatients seen per week was
23.5 ± 38.7 and 23.4 ± 14.9 respectively.
Table 2 shows the responses of the cardiologists to
questions on awareness of the guidelines. 92.1% reported
awareness of AHA guidelines, 40.7% of ESC and only
11.8% of Pakistan guidelines. Almost all (99.0%) of
respondents believed that the CHF guidelines were rele-
vant or very relevant in influencing treatment choices.
In prompted questioning, the AHA guidelines turned
out to be the most relevant (92.8%). The majority
(87.2%) of respondents reported that they closely follow
the guidelines in general. Also 75.7% of the cardiologists
reported that they were well informed with the latest
update of the guidelines they follow. The major sources
of information about CHF guidelines were reported to
be journals (80.0%) followed by internet (72.8) and post-
graduate training (63.9%).
Table 1 Background and practice details of the
cardiologists.
n (%) or
Mean ± SD
Age (years) 42.1 ± 9.7
Males 272 (89.2)
Period of cardiology practice (years) 12.4 ± 8.6
Period of treating heart failure patients
(years)
12.3 ± 8.6
Highest qualification
MBBS or equivalent basic medical degree 18 (5.9)
FCPS medicine 62 (20.3)
FCPS cardiology 52 (17.0)
MRCP 62 (20.3)
American Board of IM 5 (1.6)
American Board of IM, Subspecialty of Cardiology 5 (1.6)
Fellowship 18 (5.9)
Diploma in Cardiology 82 (26.9)
Completion of post-graduate cardiology
training
Pakistan 208 (68.2)
USA 13 (4.3)
UK or Europe 81 (26.6)
Nature of practice
Only out-patient 30 (9.8)
Only inpatient 23 (7.5)
Both 252 (82.6)
Type of cardiology practice
Non-invasive cardiologist 182 (59.7)
Interventional cardiologist 89 (29.2)
Invasive non-interventional cardiologist 34 (11.1)
Affiliation with teaching hospital 196 (64.3)
As full-time faculty 159 (81.1)
As part-time faculty 37 (18.9)
Average number of patients seen in
Outpatient 23.4 ± 14.9
Inpatient 23.5 ± 38.7
MBBS, Bachelor of Medicine Bachelor of Surgery; FCPS, Fellow of college of
Physicians and Surgeons; MRCP, Membership of the Royal Colleges of
Physicians; IM, Internal Medicine
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Table 3 shows the association of relevant variables
with awareness of AHA and ESC guidelines. Cardiolo-
gists who possessed a higher level of qualifications
reported significantly higher awareness of AHA guide-
lines than those with relatively low qualifications
(Diploma in Cardiology and MBBS or equivalent
degree): 96.6% vs. 83%, p value <0.0001. A similar pat-
tern was noted for ESC guidelines but the difference
was not significant: 44.4% vs. 33%, p value = 0.057. Car-
diologists who had spent more than five years in heart
failure practice reported significantly higher awareness
of ESC guidelines: 44% vs. 32.2%, p value = 0.046. A sig-
nificant difference was not noted for awareness of AHA
guidelines; the awareness was high regardless of the
number of years spent in heart failure practice. The nat-
ure of practice did not appear to influence awareness of
either of the guidelines. Cardiologists who had com-
pleted their post-graduate training abroad reported sig-
nificantly higher awareness of ESC guidelines than those
who completed training in Pakistan: 56.7% vs. 33.2% (p
<0.0001).
Figure 1 shows the responses of the cardiologists to
management options for the three patient scenarios
(Please see questionnaire for scenarios in appendix).
Overall, the cardiologists’ management recommenda-
tions concurred with the guidelines. However, respon-
dents did more poorly on Scenario 2 (patient presenting
with uncontrolled CHF) compared to the other two sce-
narios: 84% made only one or zero correct treatment
recommendations (out of 5 correct choices) compared
to 2% and 31% in Scenario 1 and 3 respectively. The
proportions of respondents who made recommendations
that completely matched those of the guidelines were
7% (Scenario 1), 0% (Scenario 2) and 20% (Scenario 3).
Cardiologists made wrong choices with the type of ther-
apy and the appropriate doses.
Figure 2 illustrates the perceived barriers for adher-
ence to guidelines. The top three barriers identified
Table 2 Responses to questions on awareness of guidelines
n (%)
Awareness of existing guidelines
Not aware of any 8 (2.6)
American (AHA) 281 (92.1)
European (ESC) 124 (40.7)
Pakistan 36 (11.8)
Relevance of CHF guidelines in making treatment choices
Not relevant 3 (1.0)
Relevant 165 (54.1)
Very relevant 137 (44.9)
Most relevant guidelines
AHA 283 (92.8)
ESC 42 (13.8)
Pakistan 19 (6.2)
Do you follow guidelines you are aware of closely?
Yes 266 (87.2)
Are you well informed with the latest update of the guidelines you follow?
Yes 231 (75.7)
Major source of information about CHF guidelines
My training 195 (63.9)
Colleagues 70 (23.0)
Journals 244 (80.0)
Professional meetings 180 (59.0)
Drug representatives 19 (6.2)
Internet 222 (72.8)
Journals read on a regular basis
Heart 168 (55.1)
NEJM 120 (39.3)
Circulation 182 (59.7)
Lancet 83 (27.2)
JPMA (Local indexed journal) 89 (29.2)
AHA, American Heart Association; ESC, European Society of Cardiology; JPMA, Journal of Pakistan Medical Association
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were patient compliance (59%), cost/health economics
(50%) and comorbid conditions of patients (19%). The
cardiologists were also asked about the possible strate-
gies to improve adherence to guidelines; the top three
strategies identified were availability of a compact sum-
mary format (71%), latest update by printout (59%) and
delivery of latest update by email (42%). This is shown
in Figure 3.
Responses were compared across the four cities. There
was a significant difference in responses to scenario 3,
with cardiologists from Karachi having a greater number
of correct responses (making 3 or all correct responses)
than their peers in the other three cities (67% vs. 16.7-
30.0%, p < 0.0001). When comparing responses across
cities to top three barriers to following guidelines, the
only significant difference was observed in the third bar-
rier: presence of comorbid conditions in patients. When
comparing responses across cities to top three strategies
to improve adherence, significant differences were
observed in two strategies: compact summary available
and latest update available by printout. Cardiologists
from Karachi opted for these two strategies more fre-
quently than their peers.
Table 3 Association of relevant variables with awareness of AHA and ESC guidelines on CHF
Awareness of AHA guidelines
n (%)
P value Awareness of ESC guidelines
n (%)
P value
Qualification
Low 83 (83.0) < 0.0001 33 (33.0) 0.057
High 198 (96.6) 91 (44.4)
Period of heart failure practice
≤ 5 years 71 (88.8) 0.191 25 (31.2) 0.046
> 5 years 210 (93.3) 99 (44.0)
Nature of practice
Outpatient only 26 (86.7) 0.086 7 (23.3) 0.059
Inpatient only 19 (82.6) 7 (30.4)
Both 236 (93.7) 110 (43.7)
Post-graduate training
Pakistan 191 (91.8) 0.773 69 (33.2) < 0.0001
Other 90 (92.8) 55 (56.7)
Low qualification includes Diploma in Cardiology and MBBS or equivalent degree. High includes the rest.
P value calculated using chi-square test.
 
 
 
Figure 1 Summary of responses for the three patient scenarios.
Respondents (%) with treatment changes matching those of the
panel. Scenario 1: Patient with newly-diagnosed heart failure;
Scenario 2: Patient with uncontrolled CHF; Scenario 3: Patient with
CHF and preserved left ventricular function.
Figure 2 Cardiologists’ perception of barriers for adherence to
guidelines for CHF.
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Discussion
This national survey highlights that the majority of practi-
cing cardiologists of Pakistan are aware of existence of
guidelines for heart failure and consider them relevant for
heart failure management of their patients. However,
when their grasp of the ESC guidelines was assessed by
patient scenarios, only a very few could make the manage-
ment choices exactly in accordance with the ESC guide-
lines based on an expert panel used by Erhardt et al[19].
Most common cause of heart failure is coronary artery
disease in both Europe and South Asians. However, south
Asians have a greater prevalence of premature heart dis-
ease given heavy burden of diabetes and other risk factors
[20]. This necessitates aggressive risk factor control in
Pakistani population that is tailored to fit the population
behavior and health care system of Pakistan. However,
there is no validated guideline that providers can follow.
Most physicians are trained via a European system and are
familiar with the European guidelines. It does remain a
question whether adherence to these guidelines will be
adequate to improve HF mortality in Pakistan.
Our results indicate that despite high awareness of
importance of managing patients according to guide-
lines, the knowledge was either scarce or that physicians
were unable to put that knowledge into practice. The
most frequently reported barriers to use of these guide-
lines were lack of patient compliance and cost/health
economics. Most cardiologists felt that availability of a
more compact version of the guidelines would be effec-
tive in increasing adherence to them.
Most cardiologists in Pakistan have undergone post
graduate training in Pakistan or the United Kingdom
(UK)/Europe. Postgraduate medical training within Paki-
stan resembles the UK training. We expected the practi-
cing physicians to be more aware of European.. However,
our results indicate AHA being more popular among
Pakistani physicians than the ESC guidelines. We presume
that this is inconsequential as the ESC and AHA guide-
lines are comparable in recommendations[21].
The lack of adequate adherence to recommended guide-
lines has been reported in several studies across the globe.
The Get With the Guidelines – Heart Failure Program, a
US based study conducted by Patel et al. showed patients
with increased severity of renal dysfunction and HF were
less likely to receive important guideline-recommended
therapies despite higher mortality rates[22]. IMPROVE HF
was another US based, prospective cohort study designed
to characterize the management of patients with chronic
HF and left ventricular ejection fraction ≤35% in outpati-
ent cardiology practices. They found that the adherence
for recommended adjunctive therapies was extremely low
[23]. Similarly, the EuroHeart Failure Survey program
showed that the prescription of recommended medica-
tions including ACE inhibitors and beta-blockers was lim-
ited and that the daily dose was lower than recommended
[4]. Rywik et al also pointed out the concern of underuse
of beta blockers and use of Calcium channel blockers in
HF patients in Poland, Europe[24].
We grouped MBBS and Cardiology diplomas as low
level of qualification and found that these physicians
tended to be significantly less aware of the existence of
AHA guidelines. This trend was true for the ESC guide-
lines too but did not reach significance. This is concern-
ing as almost a third of the listed cardiologists of the
country were merely MBBS or Diploma in Cardiology
and not trained well enough to follow latest evidence
published. It is imperative that some serious effort is
made to update these health care providers.
Very few physicians made all the choices as recom-
mended by the ESC guideline expert panel. Compared to
Erhardt et al., our cardiologists did very poorly for sce-
nario 2 - a 70 year old female patient with HF and with
acute exacerbation of symptoms[19]. Perhaps adherence
to guidelines is not only dependent on physician charac-
teristics but also patient profiles. The Improve HF study
by Yancy et al. showed that older patients, particularly
older women, were significantly less likely to receive
guideline-indicated HF therapies[25]. Kasje et al also
showed that guideline recommended use of ACE Inhibi-
tors was more linked to patient characteristics[26].
Our respondents did best on scenario 3 - a female
patient with CHF and preserved left ventricular function
showing that physicians were more comfortable in apply-
ing guideline recommendations in a stable patient than in
a patient with exacerbation. This finding can be used to
focus more on physician education on guideline recom-
mendations for hospitalized patients with exacerbations.
Barriers to implementation of guidelines
The cardiologists of Pakistan cited patient compliance
and cost/health economics as the most common barriers
Figure 3 Possible strategies to improve implementation of
guidelines.
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to implementation of guidelines. This is in contrast to
Erhardt et al where guideline complexity was seen as an
important barrier among respondents[19]. Barriers are
dependent on the existing health system. Pakistan is a
developing country with poor health indicators[14].
Moreover, government provided health insurance is non-
existent. To attain quality health care, the patient has to
bear the cost himself. It becomes inevitable that physi-
cians are forced to recommend suboptimal therapy to
patients with financial constraints. Sturm et al. showed
that prescribed drug volume and choice of drug regimes
for HF were country specific [27]. Therefore, health eco-
nomics is one crucial factor within the Pakistani health-
care system affecting guideline implementation.
Literature also suggests that patient factors, including
compliance, socioeconomic factors or demographics are
important in establishing guideline adherence among phy-
sicians[25,26]. A survey conducted by Keefe et al showed
that most physicians did not follow guideline recommen-
dations because the suggestions were felt to be inapplic-
able to their patients or unlikely to be tolerated [28]. In
another study, patient age >75 years remained an indepen-
dent predictor of under-prescription of CHF drugs [8].
Our physicians frequently reported patient compliance as
a barrier demonstrating that patient factors are most rele-
vant when assessing guideline adherence.
Improving adherence to guidelines
Most physicians believed that a more compact version, lat-
est update by printout and via email will help them in
implementing guidelines better in their practices. Some
interventions have been tried out previously including
standard education on guideline adherence (GA) in gen-
eral practice and new, multifaceted intervention (educa-
tional train-the-trainer course plus pharmacotherapy
feedback = TTT)[29,30]. It was seen that the TTT inter-
vention did not prove any more beneficial than conven-
tional education of physicians. Nevertheless, it is
important to take into account what physicians believe
themselves as possible ways of learning more about guide-
lines. The Pakistan Cardiac Society (PSC) can make a
summarized version available derived from AHA/ESC and
then send it to all cardiologists via printouts and emails.
Later updates can be sent the same way too. For improv-
ing adherence, we also recommend that PCS provide a list
of trade names for drugs which are cheaper so that it is
easier for physicians to overcome the cost barrier.
Limitations
The main strength of the study was its high overall
response rate (82.0%) but there were also a number of
limitations. First, since all practicing cardiologists were
not eligible to participate, this may have introduced
selection bias through the sampling method. However,
we believe that our sample was relatively representative
of the country’s cardiologists as participants were
selected from 4 major cities across Pakistan. Second,
Peshawar and Quetta were underrepresented in our
study due to their high refusal rate to participate. Third,
although we made sure to include every cardiologist
practicing in the respective city, there still is a possibility
that we may have missed a few. Fourth, this study only
assessed the performance of the cardiologists in major
cities. We cannot extrapolate these data to those practi-
cing in rural areas. That said, in Pakistan, few cardiolo-
gists practice in rural areas, and patient from these areas
have to visit major cities to access tertiary care facilities.
Fifth, the majority of the participants were men. This
was related to the paucity of the female cardiologists in
Pakistan. Additionally, results are largely dependent on
the definition of cardiologist. Finally, it should be noted
that this was a survey of physicians regarding their prac-
tices; as a result, the findings were more subjective than
they would have been in a study that used an objective
measure of performance, such as chart review. Because
physicians may overestimate their performance relative
to treatment guidelines, our results may underestimate
cardiologists’ divergence from established practices.
Conclusions
Based on our review of the indexed medical literature,
this is the first study to examine awareness of and
adherence to HF guidelines among cardiologists in Paki-
stan. The survey results indicate deviations from recom-
mended evidence-based practice, which may lead to
suboptimal treatment and patient outcomes. Cost/
Health economics is a major barrier to guideline adher-
ence specific to Pakistani cardiologists.
Additional material
Additional file 1: Questionnaire. Description: Questionnaire that was
administered to participants.
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